Dublin, Jan. 26, 2017 -- Research and Markets has announced the addition of the "Coagulation/Hemostasis Analyzer Market - Forecast to 2021" report to their offering.
The coagulation analyzer market is projected to reach USD 4.84 Billion by 2021 from USD 2.98 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021.
Based on end-users, the coagulation analyzers market are classified into clinical laboratories, PoC testing and others. The clinical laboratories segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Increasing prevalence of CVD's and the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories will drive the growth of this market.
Geographically, the coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population and increasing prevalence of CVD's.
The major factors contributing to the growth of the coagulation analyzers market include increasing high incidences of CVD's, increasing blood related disorders, and rising geriatric population. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies and high cost of fully automated hemostasis analyzers are the major factors restraining the growth of this market. The high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market.
The major players in this market include are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).
Companies Mentioned:
- Alere Inc.
- Diagnostica Stago Sas
- Helena Laboratories
- Instrumentation Laboratory (A Division of the Werfen Group)
- International Technidyne Corporation (ITC)
- Nihon Kohden Corporation
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
- Siemens Healthcare (A Division of Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Coagulation Analyzer Market, By Product
7 Coagulation Analyzer Market, By Test
8 Coagulation Analyzer Market, By Technology
9 Coagulation Analyzer Market, By Patient Care Setting
10 Coagulation Analyzer Market, By Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/8r28q4/coagulationhemost
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices, Coagulation and Hemostasis Testing


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 



